

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 7.40099860 |
| 2 | intestinal absorption (GO:0050892) | 7.10787708 |
| 3 | parturition (GO:0007567) | 6.77830591 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.64654388 |
| 5 | regulation of triglyceride catabolic process (GO:0010896) | 5.56988609 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.46849777 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.46849777 |
| 8 | angiotensin maturation (GO:0002003) | 5.46082880 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32511059 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.32511059 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 5.27902970 |
| 12 | phospholipid efflux (GO:0033700) | 5.17882443 |
| 13 | cysteine metabolic process (GO:0006534) | 5.14220888 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 5.11790030 |
| 15 | drug catabolic process (GO:0042737) | 5.05627896 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.03068541 |
| 17 | negative regulation of sterol transport (GO:0032372) | 5.02554493 |
| 18 | negative regulation of cholesterol transport (GO:0032375) | 5.02554493 |
| 19 | diacylglycerol metabolic process (GO:0046339) | 5.01562102 |
| 20 | urea metabolic process (GO:0019627) | 4.97864067 |
| 21 | urea cycle (GO:0000050) | 4.97864067 |
| 22 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.95101323 |
| 23 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.95101323 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.86055516 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 4.84367099 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.84367099 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.84367099 |
| 28 | kynurenine metabolic process (GO:0070189) | 4.80023524 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.78174455 |
| 30 | plasma lipoprotein particle assembly (GO:0034377) | 4.76389479 |
| 31 | cholesterol efflux (GO:0033344) | 4.75019323 |
| 32 | lipoprotein transport (GO:0042953) | 4.74652799 |
| 33 | glyoxylate metabolic process (GO:0046487) | 4.68943080 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.68360844 |
| 35 | lysine metabolic process (GO:0006553) | 4.63646998 |
| 36 | lysine catabolic process (GO:0006554) | 4.63646998 |
| 37 | flavonoid metabolic process (GO:0009812) | 4.59966634 |
| 38 | tryptophan metabolic process (GO:0006568) | 4.55257221 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.53054029 |
| 40 | bile acid biosynthetic process (GO:0006699) | 4.51241071 |
| 41 | low-density lipoprotein particle remodeling (GO:0034374) | 4.46602679 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45175046 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44211414 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.44211414 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.44211414 |
| 46 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.40587702 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.38730900 |
| 48 | lipoprotein metabolic process (GO:0042157) | 4.37531553 |
| 49 | protein-lipid complex assembly (GO:0065005) | 4.37035616 |
| 50 | negative regulation of protein activation cascade (GO:2000258) | 4.34414453 |
| 51 | cholesterol homeostasis (GO:0042632) | 4.32728691 |
| 52 | sterol homeostasis (GO:0055092) | 4.27898575 |
| 53 | regulation of bile acid biosynthetic process (GO:0070857) | 4.23361755 |
| 54 | lung vasculature development (GO:0060426) | 4.22445623 |
| 55 | negative regulation of complement activation (GO:0045916) | 4.15635513 |
| 56 | epoxygenase P450 pathway (GO:0019373) | 4.15306055 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.14518527 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.14518527 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.13384009 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 4.11733805 |
| 61 | regulation of protein activation cascade (GO:2000257) | 4.11239844 |
| 62 | sulfate transmembrane transport (GO:1902358) | 4.08100340 |
| 63 | complement activation, alternative pathway (GO:0006957) | 4.04454582 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.01197788 |
| 65 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.01197788 |
| 66 | regulation of cholesterol homeostasis (GO:2000188) | 3.99590775 |
| 67 | regulation of apoptotic cell clearance (GO:2000425) | 3.98023895 |
| 68 | bile acid metabolic process (GO:0008206) | 3.95444775 |
| 69 | drug transmembrane transport (GO:0006855) | 3.93326826 |
| 70 | regulation of complement activation (GO:0030449) | 3.92937741 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 3.91532782 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.91436577 |
| 73 | glycine metabolic process (GO:0006544) | 3.90746845 |
| 74 | hormone catabolic process (GO:0042447) | 3.89320309 |
| 75 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.86186139 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.85804787 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.84745337 |
| 78 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.83672025 |
| 79 | cellular glucuronidation (GO:0052695) | 3.83047347 |
| 80 | negative regulation of fibrinolysis (GO:0051918) | 3.82249140 |
| 81 | heme transport (GO:0015886) | 3.79097823 |
| 82 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.78038404 |
| 83 | positive regulation of glycolytic process (GO:0045821) | 3.75447039 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.74936502 |
| 85 | urate metabolic process (GO:0046415) | 3.74214467 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.73051948 |
| 87 | exogenous drug catabolic process (GO:0042738) | 3.71087501 |
| 88 | drug transport (GO:0015893) | 3.68581804 |
| 89 | modified amino acid transport (GO:0072337) | 3.68340014 |
| 90 | vitamin A metabolic process (GO:0006776) | 3.67419576 |
| 91 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.66953807 |
| 92 | endocrine process (GO:0050886) | 3.66953807 |
| 93 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.66953807 |
| 94 | exocrine pancreas development (GO:0031017) | 3.66879946 |
| 95 | protein carboxylation (GO:0018214) | 3.66862389 |
| 96 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66862389 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.64481235 |
| 98 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.64389610 |
| 99 | regulation of fibrinolysis (GO:0051917) | 3.64326004 |
| 100 | cellular zinc ion homeostasis (GO:0006882) | 3.61375672 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 3.60112188 |
| 102 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.59350771 |
| 103 | drug metabolic process (GO:0017144) | 3.56382692 |
| 104 | glutamate metabolic process (GO:0006536) | 3.55516887 |
| 105 | sterol transport (GO:0015918) | 3.55152050 |
| 106 | cholesterol transport (GO:0030301) | 3.55152050 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 3.50996087 |
| 108 | vitamin transmembrane transport (GO:0035461) | 3.49958478 |
| 109 | response to nitrosative stress (GO:0051409) | 3.47618470 |
| 110 | imidazole-containing compound metabolic process (GO:0052803) | 3.46500149 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.46452916 |
| 112 | protein-lipid complex subunit organization (GO:0071825) | 3.44763319 |
| 113 | cellular amino acid catabolic process (GO:0009063) | 3.41203149 |
| 114 | ethanol oxidation (GO:0006069) | 3.41130204 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.38457535 |
| 116 | glucuronate metabolic process (GO:0019585) | 3.36910184 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.36910184 |
| 118 | indolalkylamine metabolic process (GO:0006586) | 3.36242056 |
| 119 | proline metabolic process (GO:0006560) | 3.36006488 |
| 120 | lung lobe morphogenesis (GO:0060463) | 3.34959905 |
| 121 | lipid homeostasis (GO:0055088) | 3.33689003 |
| 122 | benzene-containing compound metabolic process (GO:0042537) | 3.33374383 |
| 123 | negative regulation of humoral immune response (GO:0002921) | 3.32221041 |
| 124 | sulfate transport (GO:0008272) | 3.28491812 |
| 125 | drinking behavior (GO:0042756) | 3.27974837 |
| 126 | glycerol metabolic process (GO:0006071) | 3.20467411 |
| 127 | proline biosynthetic process (GO:0006561) | 3.19636046 |
| 128 | phenol-containing compound catabolic process (GO:0019336) | 3.18840816 |
| 129 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.12640241 |
| 130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.11206448 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.09079298 |
| 132 | complement activation, classical pathway (GO:0006958) | 3.00628360 |
| 133 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.97963585 |
| 134 | positive regulation of muscle hypertrophy (GO:0014742) | 2.97963585 |
| 135 | alditol metabolic process (GO:0019400) | 2.96162882 |
| 136 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.95980602 |
| 137 | COPII vesicle coating (GO:0048208) | 2.95419567 |
| 138 | regulation of guanylate cyclase activity (GO:0031282) | 2.95354361 |
| 139 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.93701330 |
| 140 | negative regulation of metanephros development (GO:0072217) | 2.89218003 |
| 141 | negative regulation of coagulation (GO:0050819) | 2.88933720 |
| 142 | regulation of cholesterol metabolic process (GO:0090181) | 2.86974001 |
| 143 | regulation of lipoprotein metabolic process (GO:0050746) | 2.86234418 |
| 144 | regulation of systemic arterial blood pressure (GO:0003073) | 2.85258719 |
| 145 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.83188399 |
| 146 | short-chain fatty acid metabolic process (GO:0046459) | 2.76770650 |
| 147 | fructose metabolic process (GO:0006000) | 2.76168309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.66792863 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.94968691 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.66462732 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.10542124 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.49355101 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.38866046 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.09093236 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.08874330 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91693036 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.70579743 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.40114051 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.06808834 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96104772 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.92371045 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.89578157 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.45916201 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25398123 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07310181 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.06111217 |
| 20 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.02506674 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88674562 |
| 22 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.88091557 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.83028456 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.79159907 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.76878672 |
| 26 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76759433 |
| 27 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76154039 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.73423337 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72333337 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72037037 |
| 31 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.71886186 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70827591 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70814897 |
| 34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59229615 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.57899821 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57441893 |
| 37 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.55869693 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.54980840 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.52132953 |
| 40 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.51966743 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50952431 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50422827 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47227274 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40807299 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39611238 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39298241 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33614053 |
| 48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33534862 |
| 49 | GATA2_19941826_ChIP-Seq_K562_Human | 1.33291892 |
| 50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33147751 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30309747 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29916374 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27522491 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25280003 |
| 55 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.23985087 |
| 56 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.23853135 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22835620 |
| 58 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22383436 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20737990 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18470887 |
| 61 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.14789731 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14446648 |
| 63 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.14193378 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13863713 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13227646 |
| 66 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12463536 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12282281 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11578838 |
| 69 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.09824150 |
| 70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07119863 |
| 71 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03484521 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02604118 |
| 73 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.02507269 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01405352 |
| 75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01206007 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01014197 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97818517 |
| 78 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.95917074 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95674212 |
| 80 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95307120 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93732465 |
| 82 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93347330 |
| 83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93156580 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92838075 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91154200 |
| 86 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.90867000 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90236342 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88764380 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88699269 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87982254 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87462978 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87397499 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86361199 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85711748 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85529701 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84168922 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83628279 |
| 98 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.83475384 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82797330 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82797330 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82072811 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81580629 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.81280676 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80074802 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79585831 |
| 106 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79241248 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79029929 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78993327 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78618413 |
| 110 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78330977 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77992797 |
| 112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77939448 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77889729 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76984179 |
| 115 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.76836671 |
| 116 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.76836671 |
| 117 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.76836671 |
| 118 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.76646462 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.76429311 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76417245 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74468511 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74399214 |
| 123 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.73660188 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73370194 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72825846 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72196590 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.71514420 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69162314 |
| 129 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.68026961 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.67735558 |
| 131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.67670848 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.67661078 |
| 133 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.67147939 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65926365 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65797661 |
| 136 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65628483 |
| 137 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.64562396 |
| 138 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.64502036 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64233451 |
| 140 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.63753947 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.63248959 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62940444 |
| 143 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.62839594 |
| 144 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.62617975 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62142247 |
| 146 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62038138 |
| 147 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.61293311 |
| 148 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.60954704 |
| 149 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.60750789 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.60637289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.22458816 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.83593615 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.41078090 |
| 4 | MP0005365_abnormal_bile_salt | 4.46721113 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32391424 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.31512252 |
| 7 | MP0010386_abnormal_urinary_bladder | 4.21132720 |
| 8 | MP0003252_abnormal_bile_duct | 4.18153820 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 4.01423393 |
| 10 | MP0009840_abnormal_foam_cell | 3.78562166 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.30334729 |
| 12 | MP0002160_abnormal_reproductive_system | 2.77593648 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.66098186 |
| 14 | MP0005332_abnormal_amino_acid | 2.47587508 |
| 15 | MP0008004_abnormal_stomach_pH | 2.32905871 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.12048785 |
| 17 | MP0002254_reproductive_system_inflammat | 2.05494470 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.95007541 |
| 19 | MP0000609_abnormal_liver_physiology | 1.76931189 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.73412135 |
| 21 | MP0009697_abnormal_copulation | 1.72316347 |
| 22 | MP0002132_abnormal_respiratory_system | 1.68634011 |
| 23 | MP0005389_reproductive_system_phenotype | 1.67213983 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.67112857 |
| 25 | MP0004272_abnormal_basement_membrane | 1.63916990 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.62266319 |
| 27 | MP0003195_calcinosis | 1.61811114 |
| 28 | MP0005083_abnormal_biliary_tract | 1.57229974 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.49461042 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.40543751 |
| 31 | MP0003122_maternal_imprinting | 1.39419343 |
| 32 | MP0005670_abnormal_white_adipose | 1.39293599 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.32849267 |
| 34 | MP0009053_abnormal_anal_canal | 1.31851007 |
| 35 | MP0001764_abnormal_homeostasis | 1.30095135 |
| 36 | MP0003718_maternal_effect | 1.29327180 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.21995573 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.21927432 |
| 39 | MP0003879_abnormal_hair_cell | 1.21516331 |
| 40 | MP0004043_abnormal_pH_regulation | 1.16734017 |
| 41 | MP0000462_abnormal_digestive_system | 1.14754610 |
| 42 | MP0005409_darkened_coat_color | 1.12590790 |
| 43 | MP0003868_abnormal_feces_composition | 1.08482962 |
| 44 | MP0000627_abnormal_mammary_gland | 1.05853590 |
| 45 | MP0003724_increased_susceptibility_to | 1.05685525 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03142085 |
| 47 | MP0002796_impaired_skin_barrier | 1.01072295 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.00871318 |
| 49 | MP0005164_abnormal_response_to | 1.00706630 |
| 50 | MP0000598_abnormal_liver_morphology | 0.94559500 |
| 51 | MP0005266_abnormal_metabolism | 0.93207015 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 0.90250937 |
| 53 | MP0010155_abnormal_intestine_physiology | 0.89040622 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 0.88834200 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.88332682 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.87559431 |
| 57 | MP0001915_intracranial_hemorrhage | 0.87402104 |
| 58 | MP0005451_abnormal_body_composition | 0.86325357 |
| 59 | MP0003183_abnormal_peptide_metabolism | 0.86035657 |
| 60 | MP0003186_abnormal_redox_activity | 0.83878218 |
| 61 | MP0004883_abnormal_blood_vessel | 0.81203067 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.80746331 |
| 63 | MP0003632_abnormal_nervous_system | 0.79117469 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 0.79014619 |
| 65 | MP0000537_abnormal_urethra_morphology | 0.78569046 |
| 66 | MP0001873_stomach_inflammation | 0.77207920 |
| 67 | MP0004147_increased_porphyrin_level | 0.76895714 |
| 68 | MP0003953_abnormal_hormone_level | 0.74101943 |
| 69 | MP0005448_abnormal_energy_balance | 0.73402100 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.73041749 |
| 71 | MP0003938_abnormal_ear_development | 0.72571813 |
| 72 | MP0001881_abnormal_mammary_gland | 0.71231077 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.70326234 |
| 74 | MP0009642_abnormal_blood_homeostasis | 0.69845333 |
| 75 | MP0001756_abnormal_urination | 0.69773694 |
| 76 | MP0000538_abnormal_urinary_bladder | 0.69685588 |
| 77 | MP0005395_other_phenotype | 0.69083569 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.66687124 |
| 79 | MP0003878_abnormal_ear_physiology | 0.66687124 |
| 80 | MP0000467_abnormal_esophagus_morphology | 0.66386898 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.66129825 |
| 82 | MP0001849_ear_inflammation | 0.65707550 |
| 83 | MP0005408_hypopigmentation | 0.65439685 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.65110364 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.64095836 |
| 86 | MP0005501_abnormal_skin_physiology | 0.63128654 |
| 87 | MP0005023_abnormal_wound_healing | 0.59176181 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.58107899 |
| 89 | MP0001664_abnormal_digestion | 0.57675582 |
| 90 | MP0009763_increased_sensitivity_to | 0.57475228 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.57275720 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.56739348 |
| 93 | MP0003011_delayed_dark_adaptation | 0.56714027 |
| 94 | MP0009764_decreased_sensitivity_to | 0.56422570 |
| 95 | MP0000920_abnormal_myelination | 0.55702042 |
| 96 | MP0002971_abnormal_brown_adipose | 0.55374803 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.55169023 |
| 98 | MP0002938_white_spotting | 0.54901315 |
| 99 | MP0005410_abnormal_fertilization | 0.54839204 |
| 100 | MP0000604_amyloidosis | 0.54508310 |
| 101 | MP0002933_joint_inflammation | 0.54251505 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.53977686 |
| 103 | MP0003123_paternal_imprinting | 0.53856566 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.53378384 |
| 105 | MP0000383_abnormal_hair_follicle | 0.52885487 |
| 106 | MP0003699_abnormal_female_reproductive | 0.51767482 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.51615895 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.51487320 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.50907562 |
| 110 | MP0008469_abnormal_protein_level | 0.50859517 |
| 111 | MP0002135_abnormal_kidney_morphology | 0.50567848 |
| 112 | MP0001270_distended_abdomen | 0.50221883 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.49946013 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.48414043 |
| 115 | MP0002060_abnormal_skin_morphology | 0.47365482 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.46578505 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.46481838 |
| 118 | MP0005647_abnormal_sex_gland | 0.46375566 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.46296051 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.46279821 |
| 121 | MP0003631_nervous_system_phenotype | 0.46246363 |
| 122 | MP0003633_abnormal_nervous_system | 0.45781091 |
| 123 | MP0000579_abnormal_nail_morphology | 0.45504718 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.45421412 |
| 125 | MP0006054_spinal_hemorrhage | 0.45390544 |
| 126 | MP0003941_abnormal_skin_development | 0.45364642 |
| 127 | MP0010678_abnormal_skin_adnexa | 0.44811546 |
| 128 | MP0000566_synostosis | 0.44710964 |
| 129 | MP0002098_abnormal_vibrissa_morphology | 0.44544900 |
| 130 | MP0005334_abnormal_fat_pad | 0.44248853 |
| 131 | MP0003119_abnormal_digestive_system | 0.42243998 |
| 132 | MP0005220_abnormal_exocrine_pancreas | 0.42117725 |
| 133 | MP0001661_extended_life_span | 0.41950634 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.39732108 |
| 135 | MP0009115_abnormal_fat_cell | 0.39232543 |
| 136 | MP0009672_abnormal_birth_weight | 0.39062235 |
| 137 | MP0001730_embryonic_growth_arrest | 0.38304389 |
| 138 | MP0008873_increased_physiological_sensi | 0.37706712 |
| 139 | MP0000377_abnormal_hair_follicle | 0.36930601 |
| 140 | MP0001663_abnormal_digestive_system | 0.35417834 |
| 141 | MP0002822_catalepsy | 0.34514739 |
| 142 | MP0003866_abnormal_defecation | 0.34277421 |
| 143 | MP0008872_abnormal_physiological_respon | 0.34162156 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.33613375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.48936631 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.56841527 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.16205359 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.11625336 |
| 5 | Xanthomatosis (HP:0000991) | 5.82336323 |
| 6 | Flat acetabular roof (HP:0003180) | 5.31796265 |
| 7 | Hyperglycinuria (HP:0003108) | 5.30808673 |
| 8 | Deep venous thrombosis (HP:0002625) | 5.15983434 |
| 9 | Hypolipoproteinemia (HP:0010981) | 5.12672130 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.02137500 |
| 11 | Fat malabsorption (HP:0002630) | 4.65738468 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.65455216 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.65455216 |
| 14 | Acanthocytosis (HP:0001927) | 4.57270822 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 4.48038945 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42381044 |
| 17 | Epidermoid cyst (HP:0200040) | 4.35736101 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.34175339 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27666787 |
| 20 | Neonatal short-limb short stature (HP:0008921) | 4.12285031 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 4.11106904 |
| 22 | Hyperammonemia (HP:0001987) | 4.07593430 |
| 23 | Hyperglycinemia (HP:0002154) | 4.03968529 |
| 24 | Complement deficiency (HP:0004431) | 4.03258886 |
| 25 | Malnutrition (HP:0004395) | 3.97143840 |
| 26 | Abnormality of proline metabolism (HP:0010907) | 3.84889290 |
| 27 | Hydroxyprolinuria (HP:0003080) | 3.84889290 |
| 28 | Glomerulonephritis (HP:0000099) | 3.82259472 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80725482 |
| 30 | Ileus (HP:0002595) | 3.70800603 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 3.56607169 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.53550571 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.53271914 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.49897813 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 3.39545130 |
| 36 | Ketosis (HP:0001946) | 3.25525449 |
| 37 | Hemorrhage of the eye (HP:0011885) | 3.22304909 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.15369077 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14060520 |
| 40 | Hypoglycemic coma (HP:0001325) | 3.12208556 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 3.03438246 |
| 42 | Irregular epiphyses (HP:0010582) | 2.97185042 |
| 43 | Poikilocytosis (HP:0004447) | 2.94159831 |
| 44 | Abnormality of complement system (HP:0005339) | 2.92615320 |
| 45 | Gout (HP:0001997) | 2.91129893 |
| 46 | Focal segmental glomerulosclerosis (HP:0000097) | 2.90422630 |
| 47 | Breech presentation (HP:0001623) | 2.88747756 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.87969244 |
| 49 | Glomerulosclerosis (HP:0000096) | 2.80002638 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.79459448 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77674621 |
| 52 | Metabolic acidosis (HP:0001942) | 2.73281951 |
| 53 | Spastic diplegia (HP:0001264) | 2.69462000 |
| 54 | Visceral angiomatosis (HP:0100761) | 2.62445436 |
| 55 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.60537897 |
| 56 | Skin nodule (HP:0200036) | 2.58784151 |
| 57 | Joint hemorrhage (HP:0005261) | 2.58428637 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58422898 |
| 59 | Menorrhagia (HP:0000132) | 2.56366985 |
| 60 | Steatorrhea (HP:0002570) | 2.56105704 |
| 61 | Vascular calcification (HP:0004934) | 2.55998278 |
| 62 | Delayed CNS myelination (HP:0002188) | 2.55905754 |
| 63 | Hypothermia (HP:0002045) | 2.55427435 |
| 64 | Ketoacidosis (HP:0001993) | 2.55368544 |
| 65 | Pigmentary retinal degeneration (HP:0001146) | 2.51237033 |
| 66 | Hemangiomatosis (HP:0007461) | 2.49486165 |
| 67 | Hyperactive renin-angiotensin system (HP:0000841) | 2.49319961 |
| 68 | Reticulocytosis (HP:0001923) | 2.48726786 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.48316390 |
| 70 | Enlarged kidneys (HP:0000105) | 2.47603812 |
| 71 | Nephritis (HP:0000123) | 2.47080622 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 2.46102124 |
| 73 | Flat capital femoral epiphysis (HP:0003370) | 2.45582813 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 2.44917544 |
| 75 | Glycosuria (HP:0003076) | 2.44917544 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.44732998 |
| 77 | Mitral stenosis (HP:0001718) | 2.44510571 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 2.43966876 |
| 79 | Abnormality of carpal bone ossification (HP:0006257) | 2.42078515 |
| 80 | Abnormal tarsal ossification (HP:0008369) | 2.40914597 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.40596310 |
| 82 | Cupped ribs (HP:0000887) | 2.39419195 |
| 83 | Nephrolithiasis (HP:0000787) | 2.37734151 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.35313889 |
| 85 | Abnormality of vitamin B metabolism (HP:0004340) | 2.35028686 |
| 86 | Abnormality of the acetabulum (HP:0003170) | 2.32234778 |
| 87 | Flattened epiphyses (HP:0003071) | 2.31539465 |
| 88 | Myocardial infarction (HP:0001658) | 2.31348867 |
| 89 | Vertebral hypoplasia (HP:0008417) | 2.24724015 |
| 90 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.24724015 |
| 91 | Lethargy (HP:0001254) | 2.22068665 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.21295655 |
| 93 | Facial shape deformation (HP:0011334) | 2.18851813 |
| 94 | Potter facies (HP:0002009) | 2.18851813 |
| 95 | Irritability (HP:0000737) | 2.18680284 |
| 96 | Chronic diarrhea (HP:0002028) | 2.18240870 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.17677449 |
| 98 | Limited elbow extension (HP:0001377) | 2.17670539 |
| 99 | Mesangial abnormality (HP:0001966) | 2.17126747 |
| 100 | Increased mean platelet volume (HP:0011877) | 2.16389487 |
| 101 | Hyperuricemia (HP:0002149) | 2.14403451 |
| 102 | Increased purine levels (HP:0004368) | 2.14403451 |
| 103 | Cholecystitis (HP:0001082) | 2.14196535 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.14196535 |
| 105 | Esophageal varix (HP:0002040) | 2.13464971 |
| 106 | Decreased circulating renin level (HP:0003351) | 2.10549957 |
| 107 | Rickets (HP:0002748) | 2.10385328 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.10177444 |
| 109 | Abnormality of vitamin metabolism (HP:0100508) | 2.09779301 |
| 110 | Cholelithiasis (HP:0001081) | 2.09676195 |
| 111 | Abnormal cartilage morphology (HP:0002763) | 2.09341961 |
| 112 | Abnormal glucose tolerance (HP:0001952) | 2.08958782 |
| 113 | Osteomalacia (HP:0002749) | 2.07335835 |
| 114 | Large earlobe (HP:0009748) | 2.06540339 |
| 115 | Dicarboxylic aciduria (HP:0003215) | 2.04984394 |
| 116 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04984394 |
| 117 | Spinal cord compression (HP:0002176) | 2.04795099 |
| 118 | Confusion (HP:0001289) | 2.04496073 |
| 119 | Pancreatitis (HP:0001733) | 2.03382407 |
| 120 | Papillary thyroid carcinoma (HP:0002895) | 2.02498242 |
| 121 | Abnormality of the nasal septum (HP:0000419) | 2.01074611 |
| 122 | Nausea (HP:0002018) | 2.01071377 |
| 123 | Megaloblastic anemia (HP:0001889) | 1.96965401 |
| 124 | Spontaneous abortion (HP:0005268) | 1.96889587 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.96677359 |
| 126 | Enlarged epiphyses (HP:0010580) | 1.96387385 |
| 127 | Abnormal hand bone ossification (HP:0010660) | 1.96237360 |
| 128 | Hypotension (HP:0002615) | 1.95163559 |
| 129 | Hyperkalemia (HP:0002153) | 1.94310589 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93714617 |
| 131 | Purpura (HP:0000979) | 1.93024929 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90142379 |
| 133 | Hypochromic microcytic anemia (HP:0004840) | 1.89033758 |
| 134 | Hypoglycemic seizures (HP:0002173) | 1.88894076 |
| 135 | Subcapsular cataract (HP:0000523) | 1.87468550 |
| 136 | Polycythemia (HP:0001901) | 1.86940937 |
| 137 | Wide cranial sutures (HP:0010537) | 1.85180370 |
| 138 | Abnormal vertebral ossification (HP:0100569) | 1.84668979 |
| 139 | Arthropathy (HP:0003040) | 1.84003879 |
| 140 | Broad alveolar ridges (HP:0000187) | 1.83099683 |
| 141 | Autoimmune hemolytic anemia (HP:0001890) | 1.81370257 |
| 142 | Small epiphyses (HP:0010585) | 1.81213793 |
| 143 | Alopecia of scalp (HP:0002293) | 1.80465770 |
| 144 | Hyperglycemia (HP:0003074) | 1.79899739 |
| 145 | Abdominal distention (HP:0003270) | 1.79066221 |
| 146 | Scanning speech (HP:0002168) | 1.78718213 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.76150353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.63269618 |
| 2 | PIK3CA | 4.11286962 |
| 3 | BCKDK | 3.61447125 |
| 4 | EPHA2 | 3.37292305 |
| 5 | MST1R | 3.12816160 |
| 6 | LATS1 | 3.04444075 |
| 7 | AKT3 | 3.03500333 |
| 8 | FGFR3 | 2.94129976 |
| 9 | ERN1 | 2.69120987 |
| 10 | FGFR4 | 2.64094867 |
| 11 | SIK1 | 2.63754013 |
| 12 | MST4 | 2.60425567 |
| 13 | ERBB4 | 2.33134372 |
| 14 | NLK | 2.31772290 |
| 15 | PTK6 | 2.18542984 |
| 16 | BRSK2 | 2.17649598 |
| 17 | GRK6 | 2.12667330 |
| 18 | MAP3K10 | 2.06370311 |
| 19 | STK38L | 2.05252539 |
| 20 | MET | 1.94327842 |
| 21 | NEK6 | 1.77014037 |
| 22 | RET | 1.68746563 |
| 23 | PKN2 | 1.64745683 |
| 24 | NEK1 | 1.63154062 |
| 25 | RIPK1 | 1.61614160 |
| 26 | LMTK2 | 1.60450583 |
| 27 | PDGFRB | 1.48363898 |
| 28 | JAK1 | 1.47525003 |
| 29 | STK39 | 1.42290002 |
| 30 | TTK | 1.38851553 |
| 31 | MAPKAPK3 | 1.33965603 |
| 32 | EPHB2 | 1.28157170 |
| 33 | CSNK1G1 | 1.26564345 |
| 34 | PRKG2 | 1.24552739 |
| 35 | TESK2 | 1.23695243 |
| 36 | MAPK11 | 1.22573084 |
| 37 | ERBB2 | 1.22547714 |
| 38 | BCR | 1.20395846 |
| 39 | FLT3 | 1.19372629 |
| 40 | NUAK1 | 1.18884241 |
| 41 | TRPM7 | 1.17812732 |
| 42 | MAP3K2 | 1.17632498 |
| 43 | STK3 | 1.15761309 |
| 44 | STK10 | 1.15490860 |
| 45 | MAP2K2 | 1.12857507 |
| 46 | PDK2 | 1.10972437 |
| 47 | CDK6 | 1.07726017 |
| 48 | CDK12 | 1.07130746 |
| 49 | CDC42BPA | 1.06322517 |
| 50 | MAP3K8 | 1.06266864 |
| 51 | BMX | 1.05314851 |
| 52 | PTK2 | 1.04799230 |
| 53 | FER | 1.03546700 |
| 54 | PDPK1 | 1.02666600 |
| 55 | MAP3K7 | 1.02034970 |
| 56 | TGFBR2 | 1.00457176 |
| 57 | MAP3K3 | 0.99551467 |
| 58 | TAOK3 | 0.99214661 |
| 59 | LATS2 | 0.98323744 |
| 60 | BMPR2 | 0.97597099 |
| 61 | PDK3 | 0.96680118 |
| 62 | PDK4 | 0.96680118 |
| 63 | EPHB1 | 0.93883632 |
| 64 | PBK | 0.90107450 |
| 65 | WNK1 | 0.90094388 |
| 66 | PRKAA2 | 0.89902978 |
| 67 | SGK494 | 0.86730819 |
| 68 | SGK223 | 0.86730819 |
| 69 | FGFR2 | 0.86290242 |
| 70 | INSRR | 0.84379451 |
| 71 | PRKCI | 0.80562738 |
| 72 | NME1 | 0.80543391 |
| 73 | DDR2 | 0.80197311 |
| 74 | PDK1 | 0.79759325 |
| 75 | ICK | 0.79153830 |
| 76 | MELK | 0.78422042 |
| 77 | PAK4 | 0.78206260 |
| 78 | CAMKK2 | 0.77735762 |
| 79 | CDK4 | 0.76107844 |
| 80 | CSNK1G3 | 0.74694308 |
| 81 | CAMK1D | 0.73380970 |
| 82 | TYRO3 | 0.72927515 |
| 83 | SGK2 | 0.72846177 |
| 84 | MTOR | 0.70152867 |
| 85 | SGK1 | 0.65733094 |
| 86 | FGFR1 | 0.64844596 |
| 87 | LRRK2 | 0.64034434 |
| 88 | KDR | 0.64028425 |
| 89 | EIF2AK1 | 0.63828621 |
| 90 | PRKAA1 | 0.63346132 |
| 91 | ACVR1B | 0.62616279 |
| 92 | WEE1 | 0.61769608 |
| 93 | PDGFRA | 0.60855483 |
| 94 | NEK2 | 0.60364152 |
| 95 | WNK3 | 0.59876490 |
| 96 | NEK9 | 0.59638072 |
| 97 | SGK3 | 0.59537450 |
| 98 | MAPKAPK5 | 0.59189122 |
| 99 | TYK2 | 0.58578884 |
| 100 | MAP3K6 | 0.56792148 |
| 101 | GSK3A | 0.55161115 |
| 102 | RPS6KB2 | 0.54036092 |
| 103 | TRIB3 | 0.52843348 |
| 104 | JAK2 | 0.52459906 |
| 105 | DYRK1B | 0.51891987 |
| 106 | YES1 | 0.51408708 |
| 107 | BUB1 | 0.51362826 |
| 108 | AURKB | 0.51175043 |
| 109 | NTRK3 | 0.51006270 |
| 110 | EIF2AK3 | 0.50155325 |
| 111 | ABL2 | 0.50120452 |
| 112 | AKT2 | 0.50106967 |
| 113 | WNK4 | 0.49976421 |
| 114 | PIM1 | 0.49123104 |
| 115 | CSNK1G2 | 0.48413854 |
| 116 | CDK7 | 0.48360354 |
| 117 | MAP3K11 | 0.48322466 |
| 118 | MAP3K12 | 0.48165393 |
| 119 | CCNB1 | 0.47925104 |
| 120 | CAMK4 | 0.47281510 |
| 121 | MAP3K5 | 0.46731722 |
| 122 | PAK2 | 0.46261855 |
| 123 | MAP3K4 | 0.43793433 |
| 124 | RPS6KB1 | 0.43067357 |
| 125 | EPHA3 | 0.42902452 |
| 126 | MAP2K1 | 0.42419394 |
| 127 | MAP2K3 | 0.41831841 |
| 128 | MAP3K1 | 0.41515259 |
| 129 | IGF1R | 0.41097746 |
| 130 | BRD4 | 0.39669421 |
| 131 | CAMK1G | 0.39499057 |
| 132 | MAP2K4 | 0.38938853 |
| 133 | KSR2 | 0.37595894 |
| 134 | SCYL2 | 0.36995066 |
| 135 | PRKCQ | 0.36980564 |
| 136 | TEC | 0.36948287 |
| 137 | EEF2K | 0.36531909 |
| 138 | BRSK1 | 0.36249803 |
| 139 | RIPK4 | 0.34986450 |
| 140 | PRKACG | 0.33483047 |
| 141 | PLK1 | 0.31918347 |
| 142 | CSNK1E | 0.31616866 |
| 143 | PAK3 | 0.29863179 |
| 144 | PRKCZ | 0.28718176 |
| 145 | MAP2K6 | 0.27303581 |
| 146 | MAPK3 | 0.26803401 |
| 147 | STK4 | 0.26741430 |
| 148 | MATK | 0.25345323 |
| 149 | PIK3CG | 0.23963968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.40228922 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.23734952 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01361777 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.95016823 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.76556475 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67603923 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.61649191 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53578171 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39784032 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37770201 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22510511 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19723290 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14861343 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05635807 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.96467314 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95451722 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94325877 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.93751337 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.93583463 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89456131 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87913820 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.87436511 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87103860 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78646545 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.77363442 |
| 26 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77023419 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76126148 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72726223 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64402727 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60756875 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59135140 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.57027962 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53832046 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53575478 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52846312 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52804334 |
| 37 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52542067 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52452035 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48456666 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44416468 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44062907 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.43011923 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41310749 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39966453 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37712358 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31205879 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31125514 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28909731 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28049468 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18695971 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18334892 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15563498 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12842643 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.11072266 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07615817 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99949033 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99072058 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96655143 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93676523 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92406588 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92250008 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91178147 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90634966 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.88101457 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87127148 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86361843 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85874060 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85503198 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85486152 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84690166 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78635275 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74354438 |
| 73 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67152197 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67011499 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66342958 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57312950 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54975230 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51351793 |
| 79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47381067 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46916469 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45873708 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44095068 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38599412 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36283271 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34096367 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33108290 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31491602 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26688281 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26144568 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25361609 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.22142105 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.14300341 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.13373796 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.12637693 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11301015 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10579776 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.10239515 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.08936426 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08422011 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07666481 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06339756 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05622061 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04295681 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03319592 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02503362 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.1430930 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1317265 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1305822 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1180362 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1177354 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1087692 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1037615 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | -0.0721999 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0538385 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0515373 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0456793 |
| 117 | Tight junction_Homo sapiens_hsa04530 | -0.0453516 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0166452 |

